Literature DB >> 27142979

The world first two cases of severe fever with thrombocytopenia syndrome: An epidemiological study in Nagasaki, Japan.

Shintaro Kurihara1, Akira Satoh2, Fuxun Yu3, Daisuke Hayasaka3, Masayuki Shimojima4, Masato Tashiro5, Tomomi Saijo6, Takahiro Takazono5, Yoshifumi Imamura6, Taiga Miyazaki5, Misuzu Tsukamoto5, Katsunori Yanagihara7, Hiroshi Mukae6, Masayuki Saijo4, Kouichi Morita3, Shigeru Kohno6, Koichi Izumikawa8.   

Abstract

Severe fever with thrombocytopenia syndrome (SFTS) caused by the SFTS virus (SFTSV), a novel phlebovirus belonging to the family Bunyaviridae, was reported in China for the first time in 2009. We observed two cases where the SFTSV was isolated for the first time in Nagasaki, Japan, in 2005. Two males in their 60s, a farmer and a hunter, respectively, living in Nagasaki developed SFTS during the same period. The patients developed similar clinical symptoms and signs, such as fever, loss of consciousness, and multiple organ dysfunction. The farmer died and the hunter survived. A retrospective diagnosis of SFTS was made in 2013, and genetic analysis revealed that the patients were infected with different SFTSV strains. Retrospective analysis of cytokine production in non-fatal case revealed interleukin (IL)-6, IL-8 and interferon-γ level of acute phase was low and could be potential prognostic factors. As there are no epidemiological studies of positive rate of SFTSV antibody in people living in endemic areas in Japan, a field study was performed. Volunteers at high risk for tick bites, such as hunters, farmers, and soldiers, were recruited in 6 regions, including the areas where the SFTS cases occurred. Three hundred and twenty six volunteers in Nagasaki prefecture were examined and none of these tested positive for the SFTSV antibody. Our data indicates that the risk for SFTSV infection is not high in Nagasaki prefecture. Further collection of blood samples from endemic areas is warranted for the prevention of SFTSV infection.
Copyright © 2016 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antibody; Epidemiology; First cases; Severe fever with thrombocytopenia syndrome

Mesh:

Year:  2016        PMID: 27142979     DOI: 10.1016/j.jiac.2016.04.001

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN: 1341-321X            Impact factor:   2.211


  12 in total

1.  The NF-κB inhibitor, SC75741, is a novel antiviral against emerging tick-borne bandaviruses.

Authors:  Crystal A Mendoza; Satoko Yamaoka; Yoshimi Tsuda; Keita Matsuno; Carla M Weisend; Hideki Ebihara
Journal:  Antiviral Res       Date:  2020-12-06       Impact factor: 5.970

2.  Antiviral activity and mechanism of the antifungal drug, anidulafungin, suggesting its potential to promote treatment of viral diseases.

Authors:  Shu Shen; Yaxian Zhang; Zhiyun Yin; Qiong Zhu; Jingyuan Zhang; Tiantian Wang; Yaohui Fang; Xiaoli Wu; Yuan Bai; Shiyu Dai; Xijia Liu; Jiayin Jin; Shuang Tang; Jia Liu; Manli Wang; Yu Guo; Fei Deng
Journal:  BMC Med       Date:  2022-10-21       Impact factor: 11.150

3.  A scoring model for predicting prognosis of patients with severe fever with thrombocytopenia syndrome.

Authors:  Bei Jia; Xiaomin Yan; Yuxin Chen; Guiyang Wang; Yong Liu; Biyun Xu; Peixin Song; Yang Li; Yali Xiong; Weihua Wu; Yingying Hao; Juan Xia; Zhaoping Zhang; Rui Huang; Chao Wu
Journal:  PLoS Negl Trop Dis       Date:  2017-09-21

4.  A novel tick-borne phlebovirus, closely related to severe fever with thrombocytopenia syndrome virus and Heartland virus, is a potential pathogen.

Authors:  Shu Shen; Xiaomei Duan; Bo Wang; Liying Zhu; Yanfang Zhang; Jingyuan Zhang; Jun Wang; Tao Luo; Chun Kou; Dan Liu; Chuanwei Lv; Lei Zhang; Chenchen Chang; Zhengyuan Su; Shuang Tang; Jie Qiao; Abulimiti Moming; Cheng Wang; Abulikemu Abudurexiti; Hualin Wang; Zhihong Hu; Yujiang Zhang; Surong Sun; Fei Deng
Journal:  Emerg Microbes Infect       Date:  2018-05-25       Impact factor: 7.163

5.  Alterations of Gut Microbiome in the Patients With Severe Fever With Thrombocytopenia Syndrome.

Authors:  Honghai Xu; Yuanyuan Wei; Hongqiu Ma; Yanyan Liu; Yalong Zhang; Lifen Hu; Jiabin Li
Journal:  Front Microbiol       Date:  2018-10-01       Impact factor: 5.640

6.  Fine epitope mapping of glycoprotein Gn in Guertu virus.

Authors:  Jingyuan Zhang; Abulimiti Moming; Xihong Yue; Shu Shen; Dongliang Liu; Wan-Xiang Xu; Chen Wang; Juntao Ding; Yijie Li; Fei Deng; Yujiang Zhang; Surong Sun
Journal:  PLoS One       Date:  2019-10-16       Impact factor: 3.240

Review 7.  Severe fever and thrombocytopenia syndrome virus infection: Considerations for vaccine evaluation of a rare disease.

Authors:  Joel N Maslow; Jackie J Kwon; Susan K Mikota; Susan Spruill; Youngran Cho; Moonsup Jeong
Journal:  Hum Vaccin Immunother       Date:  2019-07-16       Impact factor: 3.452

8.  Activation of the NLRP3 inflammasome and elevation of interleukin-1β secretion in infection by sever fever with thrombocytopenia syndrome virus.

Authors:  Zhifeng Li; Jianli Hu; Changjun Bao; Chengfeng Gao; Nan Zhang; Carol J Cardona; Zheng Xing
Journal:  Sci Rep       Date:  2022-02-16       Impact factor: 4.379

9.  Severe Fever with Thrombocytopenia Syndrome in Cats and Its Prevalence among Veterinarian Staff Members in Nagasaki, Japan.

Authors:  Tsuyoshi Ando; Takeshi Nabeshima; Shingo Inoue; Mya Myat Ngwe Tun; Miho Obata; Weiyin Hu; Hiroshi Shimoda; Shintaro Kurihara; Koichi Izumikawa; Kouichi Morita; Daisuke Hayasaka
Journal:  Viruses       Date:  2021-06-14       Impact factor: 5.048

10.  A cluster of cases of severe fever with thrombocytopenia syndrome bunyavirus infection in China, 1996: A retrospective serological study.

Authors:  Jianli Hu; Chao Shi; Zhifeng Li; Xiling Guo; Yanhua Qian; Wenwen Tan; Xian Li; Xian Qi; Xiaoju Su; Minghao Zhou; Hua Wang; Yongjun Jiao; Changjun Bao
Journal:  PLoS Negl Trop Dis       Date:  2018-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.